Part,  Chapter, Paragraph

 1   II,     5. 10.  1| antibodies or other immunological pathways, and non immune-mediated
 2   II,     6.  3.  6|         created new, wide-ranging pathways along which infectious disease
 3  III,    10.  2.  1|          The activation of reward pathways, the brain circuitry that
 4  III,    10.  2.  4|         correlation of individual pathways in systems biology with
 5  III,    10.  4.  2|     through a number of different pathways, including their occurrence
 6  III,    10.  4.  5|  disseminated along the migration pathways of birds, responsible for
 7  III,    10.  4.  5|    studies that consider exposure pathways and biomarkers of human
 8  III,    10.  4.  5|    capacity, persistence etc; the pathways to potential receptors (
 9  III,    10.  4.  5|    studies that consider exposure pathways and biomarkers of exposure
10  III,    10.  4.  5|        evaluate chemical exposure pathways and assess the exposure
11  III,    10.  4.  5|         understanding of exposure pathways, before considering site
12   IV,    11.  6.  5|           guidelines and clinical pathways on medical practice: effectiveness
13   IV,    11.  6.  5|           Parker D et al. (2006): Pathways to patient safety: the use
14   IV,    13.  4    |     integration". It will include pathways to integrate people into